|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A01N 43/42 | |||
| A61K 31/44 |
| (11) | Number of the document | 2829265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14181930.0 |
| Date of filing the European patent application | 2009-04-24 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 48463 | 2008-04-28 | US |
| (72) |
Farr, Stephen J., US
Turanin, John, US
Hawley, Roger, US
Schuster, Jeffrey A., US
|
| (73) |
Zogenix, Inc.,
5858 Horton Street Suite 455, Emeryville CA 94608,
US
|
| (54) | Novel formulations for treatment of migraine |
| Novel formulations for treatment of migraine |